However, we evaluated the significance of PD-L1 expression analysis of CTCs in Atezo/Bev treatment by comparing 24 patients with HCC treated with lenvatinib and serially collected CTCs during treatment. The gene discussed is CD274; the disease is hepatocellular carcinoma.